Matches in SemOpenAlex for { <https://semopenalex.org/work/W2059435013> ?p ?o ?g. }
- W2059435013 endingPage "2078" @default.
- W2059435013 startingPage "2071" @default.
- W2059435013 abstract "About 60% of patients with diffuse large B-cell lymphoma (DLBCL) may be cured by primary chemotherapy with an R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) regimen. Most of the rest will die of the disease, mainly due to the occurrence of tumor drug resistance. Many efforts have been made to explain the molecular mechanisms of drug resistance in patients with cancer, including those with DLBCL. This exploratory study was designed to correlate the mRNA expression levels of candidate genes mainly involved in the doxorubicin pathway (ABCB1, GSTP1, TOPO2α, BCL2, PKCβII) with the outcome of 54 patients with DLBCL undergoing a dose-dense R-CHOP regimen. After multivariate analysis, high GSTP1 (p = 0.003) and TOPO2α (p = 0.02) gene expressions were associated with shorter overall survival and progression-free survival, respectively, suggesting that these genes may represent an unfavorable prognostic factor in the case of R-CHOP treatment. These biomarkers may be useful for selecting patients eligible for personalized chemotherapy after validation in an independent set." @default.
- W2059435013 created "2016-06-24" @default.
- W2059435013 creator A5003075828 @default.
- W2059435013 creator A5004892784 @default.
- W2059435013 creator A5008491982 @default.
- W2059435013 creator A5010571894 @default.
- W2059435013 creator A5021283633 @default.
- W2059435013 creator A5021694936 @default.
- W2059435013 creator A5039833411 @default.
- W2059435013 creator A5042372248 @default.
- W2059435013 creator A5045601117 @default.
- W2059435013 creator A5046956167 @default.
- W2059435013 creator A5061736991 @default.
- W2059435013 creator A5065465503 @default.
- W2059435013 creator A5069503603 @default.
- W2059435013 creator A5071324393 @default.
- W2059435013 creator A5087543464 @default.
- W2059435013 creator A5089632360 @default.
- W2059435013 date "2014-02-24" @default.
- W2059435013 modified "2023-09-23" @default.
- W2059435013 title "Identification of pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B-cell lymphoma" @default.
- W2059435013 cites W1512813342 @default.
- W2059435013 cites W1520555856 @default.
- W2059435013 cites W1537427513 @default.
- W2059435013 cites W1853245606 @default.
- W2059435013 cites W1853410251 @default.
- W2059435013 cites W1892527323 @default.
- W2059435013 cites W1912693401 @default.
- W2059435013 cites W1912876564 @default.
- W2059435013 cites W1949104013 @default.
- W2059435013 cites W1963593700 @default.
- W2059435013 cites W1966521619 @default.
- W2059435013 cites W1966753131 @default.
- W2059435013 cites W1969508779 @default.
- W2059435013 cites W1976564639 @default.
- W2059435013 cites W1986553661 @default.
- W2059435013 cites W2013485244 @default.
- W2059435013 cites W2018071905 @default.
- W2059435013 cites W2022221742 @default.
- W2059435013 cites W2031322795 @default.
- W2059435013 cites W2034992259 @default.
- W2059435013 cites W2037904581 @default.
- W2059435013 cites W2056653165 @default.
- W2059435013 cites W2062916253 @default.
- W2059435013 cites W2064208261 @default.
- W2059435013 cites W2069019573 @default.
- W2059435013 cites W2071861992 @default.
- W2059435013 cites W2072351874 @default.
- W2059435013 cites W2096406358 @default.
- W2059435013 cites W2103635177 @default.
- W2059435013 cites W2115898988 @default.
- W2059435013 cites W2122466461 @default.
- W2059435013 cites W2126906524 @default.
- W2059435013 cites W2140065103 @default.
- W2059435013 cites W2140485109 @default.
- W2059435013 cites W2145304413 @default.
- W2059435013 cites W2145453495 @default.
- W2059435013 cites W2147246240 @default.
- W2059435013 cites W2153230421 @default.
- W2059435013 cites W2158267770 @default.
- W2059435013 cites W2160881152 @default.
- W2059435013 cites W2161817637 @default.
- W2059435013 cites W2166900358 @default.
- W2059435013 cites W2167571754 @default.
- W2059435013 cites W2169478074 @default.
- W2059435013 cites W2171356556 @default.
- W2059435013 cites W2171924617 @default.
- W2059435013 cites W4205736005 @default.
- W2059435013 cites W4248583329 @default.
- W2059435013 doi "https://doi.org/10.3109/10428194.2013.866665" @default.
- W2059435013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24289107" @default.
- W2059435013 hasPublicationYear "2014" @default.
- W2059435013 type Work @default.
- W2059435013 sameAs 2059435013 @default.
- W2059435013 citedByCount "7" @default.
- W2059435013 countsByYear W20594350132014 @default.
- W2059435013 countsByYear W20594350132015 @default.
- W2059435013 countsByYear W20594350132016 @default.
- W2059435013 countsByYear W20594350132017 @default.
- W2059435013 countsByYear W20594350132022 @default.
- W2059435013 countsByYear W20594350132023 @default.
- W2059435013 crossrefType "journal-article" @default.
- W2059435013 hasAuthorship W2059435013A5003075828 @default.
- W2059435013 hasAuthorship W2059435013A5004892784 @default.
- W2059435013 hasAuthorship W2059435013A5008491982 @default.
- W2059435013 hasAuthorship W2059435013A5010571894 @default.
- W2059435013 hasAuthorship W2059435013A5021283633 @default.
- W2059435013 hasAuthorship W2059435013A5021694936 @default.
- W2059435013 hasAuthorship W2059435013A5039833411 @default.
- W2059435013 hasAuthorship W2059435013A5042372248 @default.
- W2059435013 hasAuthorship W2059435013A5045601117 @default.
- W2059435013 hasAuthorship W2059435013A5046956167 @default.
- W2059435013 hasAuthorship W2059435013A5061736991 @default.
- W2059435013 hasAuthorship W2059435013A5065465503 @default.
- W2059435013 hasAuthorship W2059435013A5069503603 @default.
- W2059435013 hasAuthorship W2059435013A5071324393 @default.
- W2059435013 hasAuthorship W2059435013A5087543464 @default.
- W2059435013 hasAuthorship W2059435013A5089632360 @default.